Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis

Qing-Tao Zhao; Xiao-Peng Zhang; Hua Zhang; Guo-Chen Duan

doi:10.18632/oncotarget.22557

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis

Qing-Tao Zhao, Xiao-Peng Zhang, Hua Zhang and Guo-Chen Duan _

PDF | HTML | How to cite

Oncotarget. 2017; 8:112085-112093. https://doi.org/10.18632/oncotarget.22557

Metrics: PDF 1875 views | HTML 1979 views | ?

Abstract

Qing-Tao Zhao1,*, Xiao-Peng Zhang1,*, Hua Zhang1,* and Guo-Chen Duan1

1Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang 050051, Hebei, PR China

*These authors have contributed equally to this work

Correspondence to:

Guo-Chen Duan, email: [email protected]

Keywords: platelet to lymphocyte ratio; esophageal cancer; prognosis; meta-analysis

Received: June 06, 2017 Accepted: October 28, 2017 Published: November 20, 2017

ABSTRACT

Purpose: The prognostic role of inflammation index like platelet to lymphocyte ratio (PLR) in esophageal cancer remains controversial. We evaluated the prognostic significance of PLR in esophageal cancer patients.

Methods: We searched databases to identify relevant literatures. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated. A meta-analysis was performed to evaluate the prognostic value of PLR in patients with esophageal cancer.

Results: A total of 6,699 patients from 16 studies (17 cohorts) were finally enrolled in the meta-analysis. The results demonstrate that the elevated PLR predicted poorer overall survival (OS) (HR: 1.389, 95% CI: 1.161-1.663) and disease-free survival (DFS) (HR: 1.404, 95% CI: 1.169-1.687) and cancer-specific survival (CSS) (HR: 1.686, 95% CI: 1.146-2.480) in patients with esophageal cancer. Subgroup analysis revealed that the elevated PLR was also associated with poor OS in esophageal cancer treated by surgery (HR: 1.492, 95%CI: 1.149-1.938, P<0.05) and mixed treatment (HR: 1.222, 95%CI: 1.009-1.479, P<0.05). In addition, PLR Cut-off value≤160 (HR: 1.484, 95%CI: 1.088-2.024, P<0.05) and PLR Cut-off value>160 (HR: 1.391, 95%CI: 1.161-1.666, P<0.05).

Conclusion: This meta-analysis result suggested that PLR might be a significant predicative biomarker of poor prognosis for esophageal cancer patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22557

Publication Alerts

Post-Publication Promotion

Publication Discount

Meta-Analysis:

Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis

Abstract